|
Number of AGM
Median (Q1, Q3)
|
P*
|
---|
Study group
(n=31)
|
Control group
(n=30)
|
---|
Preoperative
|
3 (2, 4)
|
3 (2, 3)
|
0.3
|
18 months Postoperative
|
1 (1,2)
|
2 (2, 2)
|
<0.001
|
P**
|
<0.001
|
<0.001
| |
- AGM Antiglaucoma medication, Q1 1st quartile, Q3 3rd quartile
- * Mann-Whitney
- ** Wilcoxon Signed Ranks test